tiprankstipranks
Advertisement
Advertisement

PCKROMA Stock Latest News

Operational Planning Around Holiday Logistics at KROMATID
Private CompaniesOperational Planning Around Holiday Logistics at KROMATID
2d ago
KROMA
KROMATID Appoints New CEO as It Deepens Focus on Genomic Integrity in Cell and Gene Therapy
PremiumPrivate Companies
KROMATID Appoints New CEO as It Deepens Focus on Genomic Integrity in Cell and Gene Therapy
14d ago
KROMA
KROMATID Names New CEO to Guide Next Phase of Growth
PremiumPrivate Companies
KROMATID Names New CEO to Guide Next Phase of Growth
16d ago
KROMA
KROMATID Appoints Matthew Hemstreet CEO to Drive Next-Phase Growth in Cell and Gene Therapy Analytics
PremiumPrivate Companies
KROMATID Appoints Matthew Hemstreet CEO to Drive Next-Phase Growth in Cell and Gene Therapy Analytics
16d ago
KROMA
KROMATID – Weekly Recap
PremiumPrivate Companies
KROMATID – Weekly Recap
21d ago
KROMA
Genomic Integrity Emerges as Strategic Focus in Cell and Gene Therapy Quality
PremiumPrivate CompaniesGenomic Integrity Emerges as Strategic Focus in Cell and Gene Therapy Quality
25d ago
KROMA
Cell and Gene Therapy Research Underscores Growing Need for Advanced Cellular Characterization
Premium
Private Companies
Cell and Gene Therapy Research Underscores Growing Need for Advanced Cellular Characterization
26d ago
KROMA
Emphasis on Advanced Cellular Characterization in Cell and Gene Therapy
Premium
Private Companies
Emphasis on Advanced Cellular Characterization in Cell and Gene Therapy
26d ago
KROMA
KROMATID Highlights Rising Demand for Genomic Integrity Analytics in Cell and Gene Therapy
PremiumPrivate Companies
KROMATID Highlights Rising Demand for Genomic Integrity Analytics in Cell and Gene Therapy
28d ago
KROMA
Genomic Characterization Demand Emerges as Focus in Cell and Gene Therapy
PremiumPrivate Companies
Genomic Characterization Demand Emerges as Focus in Cell and Gene Therapy
1M ago
KROMA
KROMATID – Weekly Recap
PremiumPrivate Companies
KROMATID – Weekly Recap
1M ago
KROMA
KROMATID Highlights Growing Need for Genomic Integrity Data in Cell and Gene Therapies
PremiumPrivate Companies
KROMATID Highlights Growing Need for Genomic Integrity Data in Cell and Gene Therapies
1M ago
KROMA
KROMATID Emphasizes Growing Demand for Genomic Integrity in Cell and Gene Therapies
PremiumPrivate CompaniesKROMATID Emphasizes Growing Demand for Genomic Integrity in Cell and Gene Therapies
1M ago
KROMA
Genomic Integrity Tools Gain Relevance as In Vivo Gene Editing Accelerates
Premium
Private Companies
Genomic Integrity Tools Gain Relevance as In Vivo Gene Editing Accelerates
1M ago
KROMA
Rising Focus on Genomic Integrity in In Vivo Gene Editing May Benefit KROMATID
Premium
Private Companies
Rising Focus on Genomic Integrity in In Vivo Gene Editing May Benefit KROMATID
1M ago
KROMA
KROMATID Highlights Growing Focus on Genomic Integrity in AAV Gene Therapies
PremiumPrivate Companies
KROMATID Highlights Growing Focus on Genomic Integrity in AAV Gene Therapies
1M ago
KROMA
KROMATID Positions Genomic Integrity Services for Growing AAV Gene Therapy Demand
PremiumPrivate Companies
KROMATID Positions Genomic Integrity Services for Growing AAV Gene Therapy Demand
1M ago
KROMA
KROMATID Highlights Genomic Integrity Services as Risk-Control Tool for Cell and Gene Therapies
PremiumPrivate Companies
KROMATID Highlights Genomic Integrity Services as Risk-Control Tool for Cell and Gene Therapies
1M ago
KROMA
KROMATID Emphasizes Early Genomic Integrity Assessment for CGT Developers
PremiumPrivate Companies
KROMATID Emphasizes Early Genomic Integrity Assessment for CGT Developers
1M ago
KROMA
KROMATID Positions Genomic Integrity Services as Risk-Reduction Tool in Drug Development
PremiumPrivate CompaniesKROMATID Positions Genomic Integrity Services as Risk-Reduction Tool in Drug Development
1M ago
KROMA
Genomic Integrity Focus Positions KROMATID in AAV Gene Therapy Value Chain
Premium
Private Companies
Genomic Integrity Focus Positions KROMATID in AAV Gene Therapy Value Chain
2M ago
KROMA
KROMATID Emphasizes Genomic Integrity Focus in AAV Gene Therapy Development
Premium
Private Companies
KROMATID Emphasizes Genomic Integrity Focus in AAV Gene Therapy Development
2M ago
KROMA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >